Tag: OTCQX:LXRP

May 15, 2019

Lexaria’s DehydraTECHTM Formulation Delivers 475% More CBD to Bloodstream after 15 Minutes than Conventional Industry Formulations

Lexaria Bioscience Corp. (CSE:LXX, OTCQX:LXRP)  (the "Company" or "Lexaria"), a drug delivery platform innovator, has proven in animal testing that...
May 7, 2019

Lexaria Bioscience Announces CBD-Beverage Formulation License Agreement with Nevada-Based Company

Lexaria Bioscience Corp. (CSE:LXX, OCTQX:LXRP) (the "Company" or "Lexaria"), a drug delivery platform innovator, announces that it has entered a...
April 25, 2019

Lexaria Bioscience Expands Advisory Board

Lexaria Bioscience Corp. (CSE:LXX, OCTQX:LXRP) (the "Company" or "Lexaria"), a drug delivery platform innovator, is pleased to announce new appointments...
April 24, 2019

Lexaria Bioscience Announces Beverage License Agreement with California-Based Cannabis Company

Lexaria Bioscience Corp. (OTCQX: LXRP) (CSE: LXX) announces that it has entered a definitive 5-year agreement, via its subsidiary Lexaria...
April 9, 2019

Lexaria Bioscience Renews Contracts with Senior Management and Cancels Options

Lexaria Bioscience Corp. (CSE:LXX, OTCQX:LXRP) (the ''Company'' or ''Lexaria''), a drug delivery platform innovator, announces that it has successfully negotiated...
January 21, 2019

Makers of Malboro Fund Lexaria’s Oral Nicotine Project

In a recent announcement, Malboro cigarette makers Altria Group Inc. (NYSE:MO) have entered into an agreement to fund R&D of...
November 13, 2018

Lexaria Bioscience Launches ChrgD+

Lexaria Bioscience Corp. (OTCQX:LXRP) (CSE:LXX) (the "Company" or "Lexaria"), a drug delivery platform innovator, announces the launch of ChrgD+, a...